Monoclonal Anti-Glycoprotein G (Lyssavirus rabies) Antibody, Human IgG1 (9E5) | GLN-M646-1mg

Monoclonal Anti-Glycoprotein G (Lyssavirus rabies) Antibody, Human IgG1 (9E5) | GLN-M646-1mg| Gentaur Distribution US, UK & Europe

Rabies virus (RABV), scientific name Rabies lyssavirus, is a deadly neurotropic virus that causes rabies in humans and animals. Rabies virus has an extremely wide host range and its transmission most often occur through the saliva of animals. Without intervention prior to disease progression, rabies has the highest case fatality of any infectious disease. RABV contains a single-stranded negative-sense RNA genome that encodes five structural proteins: nucleoprotein (N), phosphoprotein (P), matrix protein (M), glycoprotein (G), and RNA-dependent RNA polymerase (L) . Among these viral proteins, the RABV glycoprotein (RABV-G) is a pivotal player mediating virus entry and the major target of neutralizing antibodies, thus a key factor for vaccine and drug design.

Source: Rabies virus (RABV), scientific name Rabies lyssavirus, is a deadly neurotropic virus that causes rabies in humans and animals. Rabies virus has an extremely wide host range and its transmission most often occur through the saliva of animals. Without intervention prior to disease progression, rabies has the highest case fatality of any infectious disease. RABV contains a singleN/Astranded negativeN/Asense RNA genome that encodes five structural proteins: nucleoprotein (N), phosphoprotein (P), matrix protein (M), glycoprotein (G), and RNAN/Adependent RNA polymerase (L) . Among these viral proteins, the RABV glycoprotein (RABVN/AG) is a pivotal player mediating virus entry and the major target of neutralizing antibodies, thus a key factor for vaccine and drug design.

Molecule: Glycoprotein G.

Species: Human.

Tag: Human IgG1 | Human Kappa.

Conjugate: Unconjugated.

Purity: 90%.

Charactirization: PBS, pH7.4.

Storage Conditions: -20℃.

Shipping Conditions: RT